The global spirometer market is estimated to be valued at US$ 1,148.7 Mn in 2023, and is expected to exhibit a CAGR of 9.5% during the forecast period (2023-2030).
Global Spirometer Market - Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic had a multifaceted impact on the global spirometer market. Initially, there was a surge in the demand for spirometers as healthcare providers relied on them for diagnosing and monitoring respiratory issues including COVID-19 complications. However, global supply chain disruptions and manufacturing challenges led to shortages in some countries. For instance, in August 2021, the government of Canada reported a shortage of volumetric incentive spirometers.
The adoption of telehealth and remote monitoring solutions accelerated, increasing the value of spirometers with remote capabilities. Nevertheless, the postponement of non-essential medical procedures during the pandemic temporarily reduced demand in certain healthcare settings.
The pandemic also raised awareness about respiratory health, potentially driving the long-term demand for spirometry post COVID-19. According to a survey conducted by Koninklijke Philips N.V., a diversified technology company, in November 2020, COVID-19 catalysed increase in awareness for the chronic respiratory conditions across the globe. According to the survey, 72% of the respondents were familiar to chronic obstructive pulmonary disease post-pandemic compared to 52% of respondents who were aware before the pandemic. Furthermore, regulatory changes expedited device approvals and encouraged innovation.
Global Spirometer Market - Segmentation
The global spirometer market is segmented into product type, technology type, application, end user, and region.
Among all the segmentation, the flow measurement segment is expected to dominate the market over the forecast period due to increasing technological advancements in flow measurement technology spirometers.
Market Trends
Increasing partnership by key market players: The key players in the global spirometer market are focused on increasing adoption of partnership to expand their market share. For instance, in August 2022, AstraZeneca plc, a multinational pharmaceutical and biotechnology company, announced its partnership with Alveofit, an India-based technology-enabled company. The partnership aims at offering Internet of things (IoT)-enabled handheld spirometers at hospitals across India.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients